Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$115.52 USD
+0.89 (0.78%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $115.56 +0.04 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Jazz Pharmaceuticals PLC's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
JAZZ 115.52 +0.89(0.78%)
Will JAZZ be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JAZZ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JAZZ
Sarepta Therapeutics (SRPT) to Report Q2 Results: Wall Street Expects Earnings Growth
Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q2 Earnings Expected to Decline
JAZZ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength?
ALKS Down Despite Positive Top-Line Data From Narcolepsy Study
Here's Why Harmony Biosciences Is an Unconventional Cannabis Investment
Other News for JAZZ
Franklin Biotechnology Discovery Fund Q2 2025 Commentary
Aristotle Global Equity Q2 2025 Commentary
Jazz Pharmaceuticals (JAZZ) Price Target Adjusted by Morgan Stanley | JAZZ Stock News
Where Jazz Pharmaceuticals Stands With Analysts
Polaris International Equity Composite Q2 2025 Commentary